Filtered By:
Management: Food and Drug Administration (FDA)
This page shows you your search results in order of date.
Order by Relevance | Date
Total 75 results found since Jan 2013.
FDA updating warnings to improve safe use of prescription stimulants used to treat ADHD and other conditions
Listen to an audio podcast of the May 11, 2023, FDA Drug Safety Communication on warnings to improve safe use of prescription stimulants used to treat ADHD and other conditions
Source: FDA Drug Safety Podcasts - May 31, 2023 Category: Drugs & Pharmacology Authors: U.S. Food and Drug Administration, Center for Drug Evaluation and Research Source Type: podcasts
Why the Adderall Shortage Has Lasted So Long
In October 2022, the U.S. Food and Drug Administration (FDA) announced a shortage of amphetamine mixed salts—a drug category that includes Adderall, the stimulant medication often used to treat attention-deficit/hyperactivity disorder (ADHD).
In the six months since, little has changed. Numerous amphetamine mixed salts products are still in short supply, although certain manufacturers expect to release additional inventory in April or May, according to an Apr. 10 update to the American Society of Health-System Pharmacists’ (ASHP) drug shortage database.
Half a year may seem like ample time to get more of a medi...
Source: TIME: Health - April 18, 2023 Category: Consumer Health News Authors: Jamie Ducharme Tags: Uncategorized Drugs healthscienceclimate Source Type: news
Pre-Workout Powders Are Gaining Popularity. Do They Work?
If you’ve trained your social-media algorithms to serve you even a little bit of fitness content, scrolling your TikTok feed might feel like wandering the aisles of a vitamin store. Workout vlogs often feature a prominently displayed tub of something called pre-workout powder: Just mix a scoop into a glass of water, down it before exercising, and you’ll instantly become more efficient and energized during your workout.
That’s the hoped-for benefit, anyway. The reality is more of a gamble.
“Pre-workout,” a packaged powder that contains at least a dozen supplements—and usually more—...
Source: TIME: Health - April 7, 2023 Category: Consumer Health News Authors: Haley Weiss Tags: Uncategorized Diet & Nutrition healthscienceclimate Source Type: news
9 Wellness Trends to Ditch in 2023
In 2022, social media inspired many of the ways we tried to get and stay healthy—but not always for the better. Weight-loss drugs spread like wildfire online, as did our collective agreement to stop going the extra mile at work. We turned to Dr. TikTok again and again, and focused perhaps too much on body image—even when we tried to keep things positive.
The new year is the perfect time to re-evaluate these habits, experts say. Here are nine wellness trends you’d be better off ditching in 2023—plus healthier alternatives.
Weight-loss shots
Ozempic and Wegovy, two weight-loss injections that are used...
Source: TIME: Health - December 12, 2022 Category: Consumer Health News Tags: Uncategorized healthscienceclimate Research Wellbeing Source Type: news
FDA Says ADHD Medication Adderall Is in Short Supply
THURSDAY, Oct. 13, 2022 -- People with attention-deficit/hyperactivity disorder (ADHD) or narcolepsy may rely on the drug Adderall, but it is in short supply, the U.S. Food and Drug Administration announced Wednesday.
The Adderall and Adderall IR...
Source: Drugs.com - Pharma News - October 13, 2022 Category: Pharmaceuticals Source Type: news
FDA Confirms Nationwide Adderall Shortage FDA Confirms Nationwide Adderall Shortage
The US Food and Drug Administration says it is in frequent contact with all manufacturers to monitor the supply of Adderall, which is approved for treating ADHD, and to help resolve this shortage.Medscape Medical News
Source: Medscape Psychiatry Headlines - October 13, 2022 Category: Psychiatry Tags: Psychiatry News Source Type: news
FDA Says ADHD Med Adderall Is in Short Supply
THURSDAY, Oct. 13, 2022 -- People with attention-deficit/hyperactivity disorder (ADHD) or narcolepsy may rely on the drug Adderall, but it is in short supply, the U.S. Food and Drug Administration announced Wednesday.
The Adderall and Adderall IR...
Source: Drugs.com - Daily MedNews - October 13, 2022 Category: General Medicine Source Type: news
ADHD Drug Adderall in Short Supply
MONDAY, Aug. 29, 2022 -- Labor shortages at Teva Pharmaceuticals have made Adderall, a widely used attention-deficit/hyperactivity disorder (ADHD) drug, hard to find in some drugstores.
But the U.S. Food and Drug Administration noted there is no...
Source: Drugs.com - Pharma News - August 29, 2022 Category: Pharmaceuticals Source Type: news
FDA Approves Xelstrym (dextroamphetamine) Transdermal System for the Treatment of Attention-Deficit/Hyperactivity Disorder (ADHD)
Miami, FL and Jersey City, NJ - March 23, 2022 --Noven Pharmaceuticals, Inc., awholly-ownedsubsidiary of Hisamitsu Pharmaceutical Co., Inc., today announced that the U.S. Food and Drug Administration (FDA) has approved Xelstrym (dextroamphetamine)...
Source: Drugs.com - New Drug Approvals - March 23, 2022 Category: Drugs & Pharmacology Source Type: news
Startup behind first FDA-approved prescription video game raises $160M
Akili Interactive made history last summer when it won approval from the U.S. Food and Drug Administration for a prescription video game designed to treat attention deficit/hyperactivity disorder (ADHD) in children. Now, the Boston company is bringing in $160 million in new funding to fuel the development of digital treatments for a "range of chronic and acute cognitive disorders."
Source: bizjournals.com Health Care News Headlines - May 27, 2021 Category: Health Management Authors: Rowan Walrath Source Type: news
FDA Approves Qelbree (viloxazine) as First New Children ' s ADHD Drug in 10 Years
TUESDAY, April 6, 2021 -- The first new drug developed in over a decade for children with attention deficit hyperactivity disorder (ADHD) has been approved by the U.S. Food and Drug Administration.
Qelbree, also known as viloxazine, comes in a...
Source: Drugs.com - Daily MedNews - April 6, 2021 Category: General Medicine Source Type: news
Maryland biotech earns FDA approval for pediatric ADHD drug
The Food and Drug Administration has approved the Maryland biotech's ADHD treatment for kids and adolescents.
Source: bizjournals.com Health Care:Physician Practices headlines - April 6, 2021 Category: American Health Authors: Sara Gilgore Source Type: news
Rockville biotech earns FDA approval for pediatric ADHD drug
The Food and Drug Administration has approved the local biotech's ADHD treatment for kids and adolescents.
Source: bizjournals.com Health Care News Headlines - April 5, 2021 Category: Health Management Authors: Sara Gilgore Source Type: news
